UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 915

Sortiert nach

Transporters and drug therapy: Implications for drug disposition and disease

Clinical pharmacology and therapeutics, 2005-09, Vol.78 (3), p.260-277

2005

Link zum Volltext

Verfügbarkeit prüfen

Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study

Clinical pharmacology and therapeutics, 2008-08, Vol.84 (2), p.248-253

2008

Link zum Volltext

Verfügbarkeit prüfen

Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) Genotype

Clinical pharmacology and therapeutics, 2007-07, Vol.82 (1), p.33-40

2007

Link zum Volltext

Verfügbarkeit prüfen

Does Power Magnify the Expression of Dispositions?

Psychological science, 2012-05, Vol.23 (5), p.475-482

2012

Link zum Volltext

Verfügbarkeit prüfen

CYP2A6 genotype and the metabolism and disposition kinetics of nicotine

Clinical pharmacology and therapeutics, 2006-11, Vol.80 (5), p.457-467

2006

Link zum Volltext

Verfügbarkeit prüfen

Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin

Clinical pharmacology and therapeutics, 2008-11, Vol.84 (5), p.559-562

2008

Link zum Volltext

Verfügbarkeit prüfen

National Complication Rates and Disposition After Posterior Lumbar Fusion for Acquired Spondylolisthesis

Spine (Philadelphia, Pa. 1976), 2009-08, Vol.34 (18), p.1963-1969

2009

Link zum Volltext

Verfügbarkeit prüfen

UGT1A128 polymorphism as a determinant of irinotecan disposition and toxicity

The pharmacogenomics journal, 2002, Vol.2 (1), p.43-47

2002

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans

Clinical pharmacology and therapeutics, 2008-07, Vol.84 (1), p.95-103

2008

Link zum Volltext

Verfügbarkeit prüfen

Associations Between ABCC2 Polymorphisms and Cisplatin Disposition and Efficacy

Clinical pharmacology and therapeutics, 2012-06, Vol.91 (6), p.1022-1026

2012

Link zum Volltext

Verfügbarkeit prüfen

Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans

Clinical pharmacology and therapeutics, 2004-12, Vol.76 (6), p.607-617

2004

Link zum Volltext

Verfügbarkeit prüfen

Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans

Clinical pharmacology and therapeutics, 2004-09, Vol.76 (3), p.192-200

2004

Link zum Volltext

Verfügbarkeit prüfen

Measurement and Compartmental Modeling of the Effect of CYP3A5 Gene Variation on Systemic and Intrarenal Tacrolimus Disposition

Clinical pharmacology and therapeutics, 2012-12, Vol.92 (6), p.737-745

2012

Link zum Volltext

Verfügbarkeit prüfen

Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone

Clinical pharmacology and therapeutics, 2004-09, Vol.76 (3), p.250-269

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: In vivo evidence of involvement of P-glycoprotein in risperidone disposition

Clinical pharmacology and therapeutics, 2005-07, Vol.78 (1), p.43-51

2005

Link zum Volltext

Verfügbarkeit prüfen

The effect of rifampin administration on the disposition of fexofenadine

Clinical pharmacology and therapeutics, 2001-03, Vol.69 (3), p.114-121

2001

Link zum Volltext

Verfügbarkeit prüfen

The pharmacokinetics and metabolic disposition of tacrolimus: A comparison across ethnic groups

Clinical pharmacology and therapeutics, 2001-01, Vol.69 (1), p.24-31

2001

Link zum Volltext

Verfügbarkeit prüfen

The effects of the human MDR1 genotype on the expression of duodenal P‐glycoprotein and disposition of the probe drug talinolol

Clinical pharmacology and therapeutics, 2002-11, Vol.72 (5), p.572-583

2002

Link zum Volltext

Verfügbarkeit prüfen

Intestinal expression of P-glycoprotein ( ), multidrug resistance associated protein 2 ( ), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans

Clinical pharmacology and therapeutics, 2006-03, Vol.79 (3), p.206-217

2006

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells

British journal of pharmacology, 2008-02, Vol.153 (4), p.805-819

2008

Link zum Volltext

Verfügbarkeit prüfen

Dermatology in primary care: Prevalence and patient disposition

Journal of the American Academy of Dermatology, 2001-08, Vol.45 (2), p.250-255

2001

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

British journal of pharmacology, 2000-04, Vol.129 (8), p.1748-1754

2000

Link zum Volltext

Verfügbarkeit prüfen

The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates

Clinical pharmacology and therapeutics, 2006-03, Vol.79 (3), p.218-230

2006

Link zum Volltext

Verfügbarkeit prüfen

Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin

British journal of pharmacology, 2003-05, Vol.139 (1), p.35-48

2003

Link zum Volltext

Verfügbarkeit prüfen

Disposition and sterol-lowering effect of ezetimibe are influenced by single-dose coadministration of rifampin, an inhibitor of multidrug transport proteins

Clinical pharmacology and therapeutics, 2006-11, Vol.80 (5), p.477-485

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 915

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

KollektionSingle Journals

SpracheJapanisch

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(909)
Mit Volltextzugriff
(752)

Publikationsform

Artikel
(915)

Sprache

Englisch
(915)

Erscheinungsjahr

n.n

Thema

Science & Technology
(849)
Life Sciences & Biomedicine
(827)
Medical Sciences
(804)
Humans
(793)
Male
(612)
Pharmacology. Drug Treatments
(522)
Female
(514)
Pharmacology
(487)
Adult
(453)
Pharmacology & Pharmacy
(448)
Middle Aged
(315)
Aged
(231)
Animals
(168)
Fundamental And Applied Biological Sciences. Psychology
(142)
Area Under Curve
(125)
Administration, Oral
(107)
Adolescent
(105)
Drug Interactions
(95)
Aged, 80 And Over
(88)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Transporters and drug therapy: Implications for drug disposition and disease

Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study

Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) Genotype

Does Power Magnify the Expression of Dispositions?

CYP2A6 genotype and the metabolism and disposition kinetics of nicotine

Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin

National Complication Rates and Disposition After Posterior Lumbar Fusion for Acquired Spondylolisthesis

UGT1A128 polymorphism as a determinant of irinotecan disposition and toxicity

Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans

Associations Between ABCC2 Polymorphisms and Cisplatin Disposition and Efficacy

Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans

Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans

Measurement and Compartmental Modeling of the Effect of CYP3A5 Gene Variation on Systemic and Intrarenal Tacrolimus Disposition

Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone

Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: In vivo evidence of involvement of P-glycoprotein in risperidone disposition

The effect of rifampin administration on the disposition of fexofenadine

The pharmacokinetics and metabolic disposition of tacrolimus: A comparison across ethnic groups

The effects of the human MDR1 genotype on the expression of duodenal P‐glycoprotein and disposition of the probe drug talinolol

Intestinal expression of P-glycoprotein ( ), multidrug resistance associated protein 2 ( ), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans

Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells

Dermatology in primary care: Prevalence and patient disposition

Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates

Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin

Disposition and sterol-lowering effect of ezetimibe are influenced by single-dose coadministration of rifampin, an inhibitor of multidrug transport proteins

Aktive Filter

Suchergebnisse filtern